Abstract
Vascular parkinsonism (VaP) is a term used to describe a parkinsonism of vascular cause. However, only ischemic or hemorrhagic lesions in the substantia nigra or nigrostriatal pathway, leading to a reduction of dopaminergic stimulus are pure VaP. Here, we report a case of true VaP due to nigrostriatal pathway stroke with accumulation of neuromelanin in Substantia nigra. This is the first description of neuromelanin accumulation from nigrostriatal damage. Also, it can help to understand the physiopathological changes in VaP.
This is a preview of subscription content, log in via an institution to check access.
References
Bejr-Kasem Marco H, Lorenzo-Bosquet C, Alvarez-Sabin J, Hernandez-Vara J (2017) Parkinsonism related to Percheron artery infarct. J Neurol Sci 373:21–22. https://doi.org/10.1016/j.jns.2016.12.011
Cakirer S, Karaarslan E, Arslan A (2003) Spontaneously T1-hyperintense lesions of the brain on MRI: a pictorial review. Curr Probl Diagn Radiol 32(5):194–217. https://doi.org/10.1016/s0363-0188(03)00026-4
Forno LS (1983) Reaction of the substantia nigra to massive basal ganglia infarction. Acta Neuropathol 62(1–2):96–102. https://doi.org/10.1007/bf00684925
Ginat DT, Meyers SP (2012) Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis. Radiographics. 32(2):499–516. https://doi.org/10.1148/rg.322105761
Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G, Zecca L, Costa A (2016) Neuromelanin imaging and dopaminergic loss in Parkinson's disease. Front Aging Neurosci 22(8):196. https://doi.org/10.3389/fnagi.2016.00196
Kitao S, Matsusue E, Fujii S, Miyoshi F, Kaminou T, Kato S, Ito H, Ogawa T et al. (2013) Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies. Neuroradiology 55(8):947–953. https://doi.org/10.1007/s00234-013-1199-9
Monzani E, Nicolis S, Dell'Acqua S, Capucciati A, Bacchella C, Zucca FA, Mosharov EV, Sulzer D, Zecca L, Casella L (2019) Dopamine, oxidative stress and protein-quinone modifications in Parkinson's and other neurodegenerative diseases. Angew Chem Int Ed Engl. 58(20):6512–6527. https://doi.org/10.1002/anie.201811122
Nakane M, Teraoka A, Asato R, Tamura A (1992) Degeneration of the ipsilateral substantia nigra following cerebral infarction in the striatum. Stroke 23(3):328–332. https://doi.org/10.1161/01.str.23.3.328
Ogawa T, Okudera T, Inugami A, Noguchi K, Kado H, Yoshida Y, Uemura K (1997) Degeneration of the ipsilateral substantia nigra after striatal infarction: evaluation with MR imaging. Radiology 204(3):847–851
Ohe Y, Uchino A, Horiuchi Y, Maruyama H, Deguchi I, Fukuoka T, Kato Y, Nagoya H, Dembo T, Tanahashi N (2013) Magnetic resonance imaging investigation of secondary degeneration of the mesencephalic substantia nigra after cerebral infarction. J Stroke Cerebrovasc Dis 22(1):58–65. https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.06.006
Peluso S, De Rosa A, Antenora A, Lieto M, Criscuolo C, Barbieri F, Pappatà S, De Michele G et al. (2015) Efficacy of dopamine agonist treatment in delayed-onset parkinsonism due to midbrain hemorrhage. Parkinsonism Relat Disord 21(2):156–158. https://doi.org/10.1016/j.parkreldis.2014.10.029
Reimão S, Pita Lobo P, Neutel D, Correia Guedes L, Coelho M, Rosa MM, Ferreira J, Abreu D, Gonçalves N, Morgado C, Nunes RG, Campos J, Ferreira JJ et al (2015) Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients. Eur J Neurol 22(3):540–546. https://doi.org/10.1111/ene.12613
Vizcarra JA, Lang AE, Sethi KD, Espay AJ (2015) Vascular Parkinsonism: deconstructing a syndrome. Mov Disord 30(7):886–894. https://doi.org/10.1002/mds.26263
Winter B, Brunecker P, Fiebach JB, Jungehulsing GJ, Kronenberg G, Endres M (2015) Striatal infarction elicits secondary extrafocal MRI changes in ipsilateral Substantia nigra. PLoS ONE 10(9):e0136483. https://doi.org/10.1371/journal.pone.0136483
Yamanouchi H, Nagura H (1997) Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke 28(5):965–969. https://doi.org/10.1161/01.str.28.5.965
Zhang S, Wang R, Wang G (2019) Impact of dopamine oxidation on dopaminergic neurodegeneration. ACS Chem Neurosci 10(2):945–953. https://doi.org/10.1021/acschemneuro.8b00454
Zucca FA, Basso E, Cupaioli FA, Ferrari E, Sulzer D, Casella L (2014) Neuromelanin of the human substantia nigra: an update. Neurotox Res 25(1):13–23. https://doi.org/10.1007/s12640-013-9435-y
Zucca FA, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I, Sulzer D, Sarna T, Casella L (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease. Prog Neurobiol 155:96–119. https://doi.org/10.1016/j.pneurobio.2015.09.012
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Ethical approval
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mantese, C.E., Hainzenreder, T.B. Neuromelanin accumulation in Substantia nigra in vascular parkinsonism. J Neural Transm 127, 1089–1091 (2020). https://doi.org/10.1007/s00702-020-02191-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-020-02191-1